Indivior adjusts notes to about $32.33 conversion price

No bondholders converted their bonds for common stock.

Available on EDGAR 11/03/2026 - 09:11 AM EST Accepted by SEC EDGAR 11/03/2026 - 09:10 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Indivior Pharmaceuticals, Inc. (INDV) reported that the conversion rate on its 0.625% Convertible Senior Notes due 2031 increased after the board declared a Special Dividend on September 16, 2026. The rate rose from 24.0033 to 30.9355 shares per $1,000 principal amount, reflecting an approximately $32.33 conversion price per share. The rate is subject to customary adjustments upon certain events described in the Indenture.

Filing Explained

Supernus (formerly Indivior) reports no noteholder conversions, so the higher conversion rate has not produced shares through conversion; if converted, the notes now carry a larger common-share entitlement, making dilution a possibility rather than an issuance already completed.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Key Figures

Conversion rate before adjustment: 24.0033 shares per $1,000 principal amount Conversion rate after adjustment: 30.9355 shares per $1,000 principal amount Conversion price: Approximately $32.33 per share +2 more

5 metrics

Conversion rate before adjustment 24.0033 shares per $1,000 principal amount Before the Special Dividend-related adjustment

Conversion rate after adjustment 30.9355 shares per $1,000 principal amount Following the Special Dividend declared September 16, 2026

Conversion price Approximately $32.33 per share Reflects the adjusted conversion rate

Coupon 0.625% Convertible Senior Notes due 2031

Principal amount used for conversion-rate calculation $1,000 The conversion rate is stated per this principal amount

Key Terms

conversion rate, conversion price, Convertible Senior Notes, Indenture

4 terms

conversion rate financial

"conversion rate per $1,000 principal amount"

Conversion rate is the proportion of items, people or contracts that take a desired action out of the total possible — for example the share of website visitors who make a purchase, or the number of convertible bonds that are exchanged for shares. Investors care because it measures how effectively a business or financial instrument turns opportunity into real outcomes, like sales or share issuance, which directly affects revenue, cash flow and ownership dilution.

conversion price financial

"reflects a conversion price of approximately $32.33 per share"

The conversion price is the fixed price at which a convertible security, like a bond or preferred stock, can be exchanged for shares of common stock. It acts like a set rate that determines how many shares an investor can receive if they choose to convert their investment. This helps investors understand the value and potential benefits of converting their securities into company shares.

Convertible Senior Notes financial

"0.625% Convertible Senior Notes due 2031"

Convertible senior notes are a type of loan that a company issues to investors, which can be turned into company shares later on. They are called "senior" because they are paid back before other debts if the company runs into trouble. This allows investors to earn interest like a loan but also have the chance to own part of the company if its value rises.

Indenture financial

"as described in the Indenture"

An indenture is a legal agreement between a company that borrows money by issuing bonds and the people who buy those bonds. It explains the rules the company must follow, like paying back the money and keeping certain financial promises. This document helps both sides understand their rights and responsibilities.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the conversion rate for INDV’s 2031 notes?

The rate is 30.9355 shares per $1,000 principal amount, increased from 24.0033 shares following the Special Dividend declared on September 16, 2026. The adjustment reflects an approximately $32.33 conversion price per share.

Did any holders convert INDV’s 2031 notes into common stock?

No bondholders converted their bonds for common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

0001625297FALSE00016252972026-11-032026-11-03

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 3, 2026

SUPERNUS, INC.

(Exact name of registrant as specified in its charter)

Delaware			001-37835			41-2520873
(State or other jurisdiction of incorporation)			(Commission File Number)			(IRS Employer Identification No.)

9715 Key West Avenue, Rockville, MD    20850

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (301) 838-2500

not applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.001 par value per share

SUPN

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

Item 8.01 Other.

Pursuant to the terms of the Indenture, dated March 17, 2026, by and between Supernus, Inc. (f/k/a Indivior Pharmaceuticals, Inc.; the “Company” or the “Registrant”) and U.S. Bank Trust Company, National Association (the “Indenture”), governing the Company's 0.625% Convertible Senior Notes due 2031 (the “Notes”), as a result of the Special Dividend that was declared by the Company’s board on September 16, 2026, the conversion rate per $1,000 principal amount of Notes has been increased from 24.0033 shares of the Company’s common stock to 30.9355 shares of the Company’s common stock, which reflects a conversion price of approximately $32.33 per share. The conversion rate is subject to customary adjustments upon the occurrence of certain events as described in the Indenture. No bondholders converted their bonds for common stock.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						Supernus, Inc.
Date: November 3, 2026			By:			/s/ Timothy C. Dec
						Name: Timothy C. Dec
						Title: Senior Vice President and Chief Financial Officer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.7 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 22.9 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 13.3 KB